Multiparametric Cardiac Positron Emission Tomography for Cardiac Allograft Vasculopathy Surveillance After Heart Transplantation

Status: Recruiting
Location: See all (5) locations...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Cardiac allograft vasculopathy (CAV) is a common complication affecting heart transplant patients. This condition causes narrowing of the heart arteries leading to graft dysfunction. Surveillance for CAV is vital; however an ideal approach has not been established. The goal of this study is to assess whether noninvasive positron emission tomography (PET) based surveillance is non-inferior to invasive coronary angiography (ICA) surveillance.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Post heart transplant 2-10 years.

• Age ≥18 years.

• Able to provide informed consent.

Locations
Other Locations
Canada
University of Calgary
NOT_YET_RECRUITING
Calgary
Mazankowski Alberta Heart Institute
NOT_YET_RECRUITING
Edmonton
Montreal Heart Institute
NOT_YET_RECRUITING
Montreal
University of Ottawa Heart Institute
RECRUITING
Ottawa
Toronto-General Hospital - University Health Network
NOT_YET_RECRUITING
Toronto
Contact Information
Primary
Sharon Chih
schih@ottawaheart.ca
613-696-7000
Backup
Heather Ross
heather.ross@uhn.ca
Time Frame
Start Date: 2024-01-08
Estimated Completion Date: 2029-03
Participants
Target number of participants: 576
Treatments
Other: Invasive Coronary Angiography
Patients in this arm will undergo annual CAV surveillance with ICA
Other: Positron Emission Tomography
Patients in this arm will undergo annual CAV surveillance with PET
Related Therapeutic Areas
Sponsors
Collaborators: Canadian Institutes of Health Research (CIHR)
Leads: Ottawa Heart Institute Research Corporation

This content was sourced from clinicaltrials.gov